Thymus Lymphoma — Trials

Thymus Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

127 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 58
Recruiting: 33
Ph III recruiting: 0
Growth YoY: —
Industry share: 24%
Top sponsor: University of Washington
Termination share: 30.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (13)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01787409	Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency	active not recruiting	N/A	565	Mayo ClinicOTHER	1	Jun 16, 2026	clinicaltrials
NCT01599559	Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma	active not recruiting	N/A	540	International Extranodal Lymphoma Study Group (IELSG)OTHER